Search Results

Paliperidone palmitate - review of the efficacy, safety and cost of a new second-generation depot antipsychotic medication

Author: Citrome, L.

Source: International Journal of Clinical Practice, Volume 64, Number 2, January 2010 , pp. 216-239(24)

Publisher: Blackwell Publishing

Paliperidone/risperidone: Obsessive-compulsive disorders (paliperidone) and weight gain (risperidone): case report

Source: Reactions, Volume 1, Number 1270, 2009-09-19 , pp. 29-29(1)

Publisher: Adis International

Population Pharmacokinetics of Intramuscular Paliperidone Palmitate in Patients with Schizophrenia: A Novel Once-Monthly, Long-Acting Formulation of an Atypical Antipsychotic

Authors: Samtani, Mahesh N.; Vermeulen, An; Stuyckens, Kim

Source: Clinical Pharmacokinetics, Volume 48, Number 9, 1 September 2009 , pp. 585-600(16)

Publisher: Adis International

Optimize the benefits and minimize the adverse effects of antipsychotics in patients with acute schizophrenia

Author: Adis International Limited,

Source: Drugs & Therapy Perspectives, Volume 25, Number 10, October 2009 , pp. 12-16(5)

Publisher: Adis International

Iloperidone for schizophrenia: a review of the efficacy and safety profile for this newly commercialised second-generation antipsychotic

Author: Citrome, L.

Source: International Journal of Clinical Practice, Volume 63, Number 8, August 2009 , pp. 1237-1248(12)

Publisher: Blackwell Publishing

Drugs in development for the treatment of schizophrenia

Author: Emsley, Robin

Source: Expert Opinion on Investigational Drugs, Volume 18, Number 8, August 2009 , pp. 1103-1118(16)

Publisher: Informa Healthcare

Reliability, validity and ability to detect change of the clinician-rated Personal and Social Performance scale in patients with acute symptoms of schizophrenia

Authors: Patrick, Donald L.; Burns, Tom; Morosini, Pierluigi; Rothman, Margaret; Gagnon, Dennis D.; Wild, Diane; Adriaenssen, Ines

Source: Current Medical Research and Opinion, Volume 25, Number 2, February 2009 , pp. 325-338(14)

Publisher: Informa Healthcare

Impact of psychotic relapse definitions in assessing drug efficacy and costs: comparison of quetiapine XR, olanzapine and paliperidone ER*

Authors: Knapp, Martin; Locklear, Julie; Järbrink, Krister

Source: Current Medical Research and Opinion, Volume 25, Number 7, July 2009 , pp. 1593-1603(11)

Publisher: Informa Healthcare

Neuroleptic Malignant Syndrome Associated with Atypical Antipsychotic Drugs

Authors: Trollor, Julian N.; Chen, Xiaohua; Sachdev, Perminder S.

Source: CNS Drugs, Volume 23, Number 6, 30 May 2009 , pp. 477-492(16)

Publisher: Adis International

Expected clinical benefits of paliperidone extended-release formulation when compared with risperidone immediate-release

Authors: Pani, Luca; Marchese, Giorgio

Source: Expert Opinion on Drug Delivery, Volume 6, Number 3, March 2009 , pp. 319-331(13)

Publisher: Informa Healthcare

Secondary delusional parasitosis treated with paliperidone

Authors: Freudenmann, R. W.; Kühnlein, P.; Lepping, P.; Schönfeldt-Lecuona, C.

Source: Clinical & Experimental Dermatology, Volume 34, Number 3, April 2009 , pp. 375-377(3)

Publisher: Blackwell Publishing

Editorial

Author: Wernicke, Joachim F.

Source: Current Drug Therapy, Volume 4, Number 1, January 2009 , pp. 1-1(1)

Publisher: Bentham Science Publishers

Paliperidone: A Clinical Review

Author: Green, Ben

Source: Current Drug Therapy, Volume 4, Number 1, January 2009 , pp. 7-11(5)

Publisher: Bentham Science Publishers

One-year clinical and economic consequences of oral atypical antipsychotics in the treatment of schizophrenia

Authors: Edwards, Natalie C.; Pesa, Jacqueline; Meletiche, Dennis M.; Engelhart, Luella; Thompson, Ann K.; Sherr, Jay; Dirani, Riad

Source: Current Medical Research and Opinion, Volume 24, Number 12, December 2008 , pp. 3341-3355(15)

Publisher: Informa Healthcare

Profile of paliperidone extended release: review of efficacy and safety data

Authors: Narasimhan, Meera; Srinivasan, Shilpa; Pae, Chi Un; Masand, Prakash

Source: Expert Review of Clinical Pharmacology, Volume 1, Number 6, November 2008 , pp. 737-744(8)

Publisher: Expert Reviews

Paliperidone: First report of atrial fibrillation and tonic-clonic seizures: case report

Source: Reactions, Volume 1, Number 1230, 2008-11-29 , pp. 28-28(1)

Publisher: Adis International

Upcoming Agents for the Treatment of Schizophrenia: Mechanism of Action, Efficacy and Tolerability

Authors: Bishara, Delia; Taylor, David

Source: Drugs, Volume 68, Number 16, 2008 , pp. 2269-2292(24)

Publisher: Adis International

What are the nursing implications when using paliperidone prolonged release for people with schizophrenia

Author: JONES, A.

Source: Journal of Psychiatric & Mental Health Nursing, Volume 15, Number 10, December 2008 , pp. 792-799(8)

Publisher: Blackwell Publishing

Paliperidone puts in performance for schizoaffective disorder

Source: Inpharma, Volume 1, Number 1663, 2008-11-08 , pp. 16-16(1)

Publisher: Adis International

Escitalopram/paliperidone interaction: First report of an interaction, leading to extrapyramidal disorders: case report

Source: Reactions, Volume 1, Number 1221, 2008-09-27 , pp. 14-14(1)

Publisher: Adis International